Healthcare provider profile · identity verified

Mitchell S Humphrey, DO

Family Practice · ERIE, PA · NPI 1538168315

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	600	176
Amlodipine Besylate	Amlodipine Besylate	401	101
Lisinopril	Lisinopril	345	103
Pantoprazole Sodium	Pantoprazole Sodium	310	81
Levothyroxine Sodium	Levothyroxine Sodium	229	74
Metformin Hcl	Metformin Hcl	192	56
Metoprolol Succinate	Metoprolol Succinate	187	49
Lorazepam	Lorazepam	177	45
Gabapentin	Gabapentin	173	40
Losartan Potassium	Losartan Potassium	173	52
Triamcinolone Acetonide	Triamcinolone Acetonide	169	76
Ezetimibe	Ezetimibe	168	45
Omeprazole	Omeprazole	167	53
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	165	40
Hydrochlorothiazide	Hydrochlorothiazide	155	50
Sertraline Hcl	Sertraline Hcl	148	39
Metoprolol Tartrate	Metoprolol Tartrate	144	42
Rosuvastatin Calcium	Rosuvastatin Calcium	139	41
Simvastatin	Simvastatin	139	40
Furosemide	Furosemide	132	41
Eliquis	Apixaban	125	23
Tamsulosin Hcl	Tamsulosin Hcl	120	32
Duloxetine Hcl	Duloxetine Hcl	96	24
Prednisone	Prednisone	95	62
Citalopram Hbr	Citalopram Hydrobromide	94	20
Meloxicam	Meloxicam	85	24
Clopidogrel	Clopidogrel Bisulfate	84	26
Allopurinol	Allopurinol	83	24
Tramadol Hcl	Tramadol Hcl	82	19
Fluticasone Propionate	Fluticasone Propionate	77	28
Zolpidem Tartrate	Zolpidem Tartrate	74	18
Pravastatin Sodium	Pravastatin Sodium	72	19
Atenolol	Atenolol	71	24
Metformin Hcl Er	Metformin Hcl	70	20
Famotidine	Famotidine	64	15
Donepezil Hcl	Donepezil Hcl	63	11
Synthroid	Levothyroxine Sodium	63	18
Celecoxib	Celecoxib	59	18
Escitalopram Oxalate	Escitalopram Oxalate	57	17
Fluoxetine Hcl	Fluoxetine Hcl	57	12
Potassium Chloride	Potassium Chloride	57	15
Mounjaro	Tirzepatide	55	suppressed
Clonazepam	Clonazepam	54	11
Diazepam	Diazepam	54	14
Pregabalin	Pregabalin	53	15
Finasteride	Finasteride	49	13
Xarelto	Rivaroxaban	49	13
Jardiance	Empagliflozin	47	12
Dicyclomine Hcl	Dicyclomine Hcl	45	suppressed
Ozempic	Semaglutide	45	suppressed
Diclofenac Sodium	Diclofenac Sodium	44	15
Albuterol Sulfate Hfa	Albuterol Sulfate	43	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	13
Mirtazapine	Mirtazapine	40	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	11
Fenofibrate	Fenofibrate	38	12
Warfarin Sodium	Warfarin Sodium	38	suppressed
Buspirone Hcl	Buspirone Hcl	37	suppressed
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	11
Glimepiride	Glimepiride	35	suppressed
Ketoconazole	Ketoconazole	35	22
Montelukast Sodium	Montelukast Sodium	35	suppressed
Oxycodone Hcl	Oxycodone Hcl	35	suppressed
Alendronate Sodium	Alendronate Sodium	34	13
Olmesartan Medoxomil	Olmesartan Medoxomil	34	suppressed
Trazodone Hcl	Trazodone Hcl	34	12
Hydroxyzine Hcl	Hydroxyzine Hcl	31	suppressed
Nifedipine Er	Nifedipine	30	suppressed
Azithromycin	Azithromycin	29	20
Valsartan	Valsartan	29	suppressed
Carvedilol	Carvedilol	28	suppressed
Fenofibrate	Fenofibrate,micronized	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Naproxen	Naproxen	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	23	19
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Bumetanide	Bumetanide	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Midodrine Hcl	Midodrine Hcl	22	suppressed
Minocycline Hcl	Minocycline Hcl	22	13
Azelastine Hcl	Azelastine Hcl	21	suppressed
Baclofen	Baclofen	21	11
Ibuprofen	Ibuprofen	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Alprazolam	Alprazolam	20	suppressed
Cephalexin	Cephalexin	20	15
Glipizide Er	Glipizide	20	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Mupirocin	Mupirocin	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Ammonium Lactate	Ammonium Lactate	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Glipizide	Glipizide	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error